The acquired technologies are applicable to both the water and wastewater treatment markets globally, which was a key driver behind the acquisition reflecting Bluewater Bio’s existing international footprint. The technologies will be marketed by Bluewater FilterClear, a newly formed subsidiary.
FilterClear technologies have to date shown impressive performance in over 60 commercial installations, including applications in desalination, municipal wastewater and potable water filtration.
Key defining features that make the technology attractive to existing customers include the unusually high throughput rate and solids retention that can be achieved, the high dirt holding capacity and low volume of backwash waste, making it potentially the best available technology for a number of important filtration applications, the company said.
The high throughput of 20-50 m3/h enables a highly compact footprint and delivers associated capital expenditure savings on space, filter vessels and peripheral equipment. Spruce media provides efficient suspended solids removal to produce filtrate to a high level of quality normally associated with membrane and cartridge filtration.
The high dirt-holding capacity of the media enables longer cycles between backwash and minimum backwash volume. Together these attributes enable low energy and reduced or zero chemical consumption.
The filter comprises typically four layers of media with highly specified materials, densities, particle sizes distribution and shape characteristics. There are four variants for optimum performance in different applications or water types, and an extensive, growing database of performance in over 60 commercial installations with different water characteristics and suspended solids particle loads.
Daniel Ishag, CEO Bluewater Bio, said: “Bluewater Bio is extremely pleased to have acquired this exciting collection of technologies from FilterClear, at a stage when they are ready to scale into key international markets for potable, desalination and tertiary wastewater treatment.”
Source: Bluewater Bio
© FoodBev Media Ltd 2024